Welcome to our dedicated page for Wns Hldgs SEC filings (Ticker: WNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The WNS (Holdings) Limited SEC filings archive provides a regulatory record of the company’s life as a publicly traded issuer on the New York Stock Exchange under the symbol WNS and its subsequent transition into a wholly owned subsidiary of Capgemini S.E. As a digital-led business transformation and services company in the data processing and hosting space, WNS used its SEC reports to disclose financial performance, risk factors, and material events.
Investors and researchers can review periodic reports such as annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) to analyze WNS’s revenue, profit, cash flows, and balance sheet, as well as management’s discussion and analysis of its operations. These filings are particularly relevant for understanding how WNS described its digital-led services, client base, and global delivery footprint over time.
The archive also includes current reports on Form 8-K that document key corporate events. In 2025, a series of 8-K filings detailed the announcement of the proposed acquisition by Capgemini, publication of the scheme document, recommendations from proxy advisory firms, shareholder approval of the scheme of arrangement, receipt of regulatory clearances, sanction of the scheme by the Royal Court of Jersey, and, on October 17, 2025, completion of the transaction that made WNS a wholly owned subsidiary of Capgemini.
Two additional filings are central to WNS’s trading status. A Form 25 filed on October 17, 2025, by the New York Stock Exchange initiated the removal of WNS ordinary shares from listing and registration under Section 12(b) of the Exchange Act. Subsequently, a Form 15 filed on October 27, 2025, certified the termination of registration of WNS’s ordinary shares under Section 12(g) and the suspension of its reporting obligations under Sections 13 and 15(d). The Form 15 notes that there was one holder of record as of the certification date.
On Stock Titan, these filings can be paired with AI-powered summaries that explain the structure and implications of documents such as 8-Ks, Form 25, and Form 15 in clear language. This helps users quickly understand how WNS’s regulatory disclosures reflect its shift from a listed NYSE company to a private subsidiary within Capgemini, while still allowing detailed review of the original SEC documents when needed.
WNS (Holdings) Limited – Q1 FY26 (quarter ended 30 Jun 2025)
- Revenue grew 9.5 % YoY to $353.8 m.
- Gross profit $116.6 m; margin 32.9 % (-2.3 pp).
- Operating income $33.1 m (-14 % YoY); operating margin 9.4 %.
- Net income $21.8 m (-24.8 %); diluted EPS $0.48 vs $0.61.
Cash from operations improved to $29.5 m, but $75.4 m was spent on share buy-backs, reducing cash to $100.9 m (-6 % q-o-q). Total debt slipped to $212.0 m while short-term borrowings climbed to $55 m.
The company cancelled 4.1 m treasury shares, cutting shares outstanding 7.5 % to 42.9 m. Share-based compensation expense was $11.7 m.
WNS closed the $66.1 m acquisition of Haukea Holdings (Kipi.ai), adding $53.9 m goodwill and expanding analytics/AI capabilities. Lease ROU assets rose $20.9 m as additional delivery-center space was secured.
Other comprehensive income of $2.0 m reflected INR strength partly offset by hedge losses. Management highlights FX volatility, client concentration, competitive BPM dynamics and the pending Capgemini S.E. takeover as key risks.
WNS (Holdings) Limited (NYSE: WNS) has furnished an 8-K to disclose the next procedural step in its pending acquisition by Capgemini S.E. The company has released the Scheme Document and related proxy materials, starting the formal shareholder approval process required under Jersey law. Two shareholder votes—a Court-sanctioned meeting and a General Meeting—are scheduled for 29 Aug 2025. Approval of the Scheme and the related amendment of WNS’s Articles of Association are key conditions to closing.
The filing supplies a press release (Ex. 99.1), the full Scheme Document (Ex. 99.2) and associated notices and proxy cards (Exs. 99.3-99.6). The information is furnished under Item 7.01 and is therefore not deemed "filed" for liability purposes. Forward-looking statements outline typical deal risks, including potential failure to receive shareholder or regulatory approvals, possible termination of the agreement, business disruption, and transaction costs. No financial terms were updated in this filing, but today’s release confirms the transaction timeline and keeps the deal on track toward an expected closing once all conditions are satisfied.
WNS (Holdings) Limited has signed a Transaction Agreement with Capgemini S.E. under which Capgemini will acquire all outstanding WNS ordinary shares via a Jersey court-sanctioned scheme of arrangement for $76.50 in cash per share. The deal covers all equity, including the cash settlement of vested RSUs and a contractual cash-settlement mechanism for 80% of unvested RSUs, which will continue to vest on their original schedules.
Key conditions include (i) antitrust and regulatory clearances in the U.S., U.K. and other jurisdictions, (ii) approval of the scheme by a majority in number representing at least 75% of votes cast by WNS shareholders, and (iii) sanction by the Royal Court of Jersey. No financing contingency applies. Closing is targeted by year-end 2025, with an outside date of 7 April 2026 (extendable to 7 August 2026).
The agreement contains customary representations, covenants and “no-shop” restrictions, with fiduciary-out provisions for superior proposals. Termination fees are significant: $118 million payable by WNS in specified circumstances (including board change-of-recommendation) and $169 million payable by Capgemini for intentional, material breaches of its regulatory-filing obligations. The transaction is not subject to financing; Capgemini commits to divestitures or other remedies required by regulators.
Following completion, WNS shares will be delisted from NYSE and deregistered under the Exchange Act. Directors owning ~1.9% of the shares have entered into voting agreements supporting the scheme.